A Michigan man has filed a lawsuit against Fresenius Medical Care, the maker of GranuFlo, a dialysate used during kidney dialysis to counteract the acids created by failing kidneys. GranuFlo was recalled in 2012 after an internal Fresenius memo discussing how it may increase the risk of cardiac arrest by as many as eight times was leaked to the FDA.
GranuFlo enjoyed wide use nationwide and has been included in the treatments of more than 250,000 people.
The lawsuit alleges the man’s cardiac arrest is a result of being treated with GranuFlo. It seeks $6 million in damages for medical costs, pain and suffering, lost wages, and future earnings. One of its major accusations is that the company failed to warn the public and the medical community of GranuFlo’s potential dangers.
As more people become aware of the risks associated with GranuFlo, there will likely be more suits filed.